1. Home
  2. DRUG vs TMCI Comparison

DRUG vs TMCI Comparison

Compare DRUG & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRUG
  • TMCI
  • Stock Information
  • Founded
  • DRUG 2019
  • TMCI 2014
  • Country
  • DRUG United States
  • TMCI United States
  • Employees
  • DRUG N/A
  • TMCI N/A
  • Industry
  • DRUG Pharmaceuticals and Biotechnology
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • DRUG Health Care
  • TMCI Health Care
  • Exchange
  • DRUG Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • DRUG 364.8M
  • TMCI 401.8M
  • IPO Year
  • DRUG N/A
  • TMCI 2021
  • Fundamental
  • Price
  • DRUG $56.97
  • TMCI $3.05
  • Analyst Decision
  • DRUG Strong Buy
  • TMCI Hold
  • Analyst Count
  • DRUG 9
  • TMCI 6
  • Target Price
  • DRUG $81.67
  • TMCI $7.07
  • AVG Volume (30 Days)
  • DRUG 190.6K
  • TMCI 889.7K
  • Earning Date
  • DRUG 12-30-2025
  • TMCI 11-06-2025
  • Dividend Yield
  • DRUG N/A
  • TMCI N/A
  • EPS Growth
  • DRUG N/A
  • TMCI N/A
  • EPS
  • DRUG N/A
  • TMCI N/A
  • Revenue
  • DRUG N/A
  • TMCI $218,879,000.00
  • Revenue This Year
  • DRUG N/A
  • TMCI $10.63
  • Revenue Next Year
  • DRUG N/A
  • TMCI $9.43
  • P/E Ratio
  • DRUG N/A
  • TMCI N/A
  • Revenue Growth
  • DRUG N/A
  • TMCI 7.90
  • 52 Week Low
  • DRUG $23.18
  • TMCI $2.96
  • 52 Week High
  • DRUG $70.23
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • DRUG 49.89
  • TMCI 13.63
  • Support Level
  • DRUG $55.01
  • TMCI $3.40
  • Resistance Level
  • DRUG $61.81
  • TMCI $4.81
  • Average True Range (ATR)
  • DRUG 3.80
  • TMCI 0.42
  • MACD
  • DRUG -0.06
  • TMCI -0.37
  • Stochastic Oscillator
  • DRUG 61.06
  • TMCI 2.28

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: